← Back to home

Document 19244749

AI Analysis

Summary: The document is a toxicology report from NMS Laboratories, detailing the examination of a specimen (femoral blood) for synthetic cannabinoids. The analysis did not reveal any positive findings of toxicological significance. The report is certified by a Forensic Toxicologist and provides details on the tests performed and reporting limits.
Significance: This document is potentially important as it provides the results of a toxicology test, specifically screening for synthetic cannabinoids, which may be relevant in a legal or investigative context.
Key Topics: Toxicological analysis results Synthetic cannabinoids screening Specimen examination findings
Key People:
  • (b)(6); (b)(7)(C) - Forensic Toxicologist at NMS Laboratories
Document Type
Report
Date
August 22, 2019
Pages
1
Folder
IMAGES010

Full Text

Page 3242 NMS LABS CONFIDENTIAL Workorder 19244749 Chain 19244749 Patient ID NP Page 2 of 2 Detailed Findings: Examination of the specimen(s) submitted did not reveal any positive findings of toxicological significance by procedures outlined in the accompanying Analysis Summary. Unless alternate arrangements are made by you, the remainder of the submitted specimens will be discarded one (1) year from the date of this report; and generated data will be discarded five (5) years from the date the analyses were performed. CERTIFICATION: Pursuant to New York Criminal Procedure Law Section 190.30(2), I certify that this report was made by me or is a true copy thereof for testing conducted at NMS Laboratories. I further certify that I am authorized by NMS Laboratories to make this certification. Workorder 19244749 was electronically signed on 08/22/2019 16:36 by: (b)(6); (b)(7)(C) F-ABFT Forensic Toxicologist Analysis Summary and Reporting Limits: All of the following tests were performed for this case. For each test, the compounds listed were included in the scope. The Reporting Limit listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present. Acade 956B - Synthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for: Compound Rpt. Limit Compound Rpt. Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5-fluoro-EDMB-PINACA 0.10 ng/mL MDMB-CHMCZCA 0.10 ng/mL 5-fluoro-MDMB-PICA 0.10 ng/mL MDMB-CHMICA 0.10 ng/mL 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 0.20 ng/mL MDMB-CHMINAC 0.10 ng/mL 5-fluoro-MMB-PINACA 0.050 ng/mL MDMB-FUBICA 0.10 ng/mL 5-fluoro-NA-PIC 1.0 ng/mL MDMB-FUBINACA / EMB-FUBINACA 0.10 ng/mL 5-fluoro-QU-PINAC 1.0 ng/mL MMB-CHMICA 0.10 ng/mL ADAMANTYL-FUBINACA 0.20 ng/mL MMB-CHMINACA 0.20 ng/mL ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/mL NMS v.18.0 DOJ-OGR-00026831